Mentor: Dr. Bradley A. Maron
Shelsey W. Johnson obtained her Bachelor of Arts degree in neuroscience and economics from Middlebury College in 2011 and Doctor of Medicine from the Geisel School of Medicine at Dartmouth in 2016. She then went on to complete her internal medicine residency training at Massachusetts General Hospital and her pulmonary and critical care medicine fellowship at Boston University Medical Center (BUMC). At BUMC, she joined Dr. Renda Soylemez Wiener in studying off-label use of therapies approved for pulmonary arterial hypertension (PAH) in lung-disease associated pulmonary hypertension.
Under the dual mentorship of Dr. Wiener and Dr. Bradley A. Maron at the Brigham and Women’s Hospital (BWH), she was awarded an NIH Ruth L. Kirschstein Postdoctoral F32 award entitled, “Novel methods to sub-phenotype patients with pulmonary hypertension due to chronic lung disease with implications for treatment.” In July 2022, she will begin her two-year Burke Advanced Fellowship in Pulmonary Heart Disease at the BWH. During this time and through this award, she will work to identify sub-phenotypes of lung-disease PH patients using cluster analysis to potentially uncover variable responses in lung disease-PH patients to existing PAH therapies.
Keywords
- Pulmonary hypertension
- Lung-disease associated pulmonary hypertension
- Inhaled treprostinil
- Off-label prescribing of pulmonary arterial hypertension therapies